Ilan Daskal
CIK 1446964 · View on SEC EDGAR ↗
Insider
First SEC filing: Nov. 14, 2023 · Latest: Nov. 14, 2023
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
0 buys (P)
3 sells (S)
Net:
$-2,972,994
+ 80 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
80 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 2, 2025 | VIAV | S | 105,191 | $17.43 | $1,833,479 | 10,132 Direct | -91.21% | Disposed | 127.1% (price as of 2026-08-19) |
| Dec. 2, 2025 | VIAV | S | 39,709 | $17.42 | $691,731 | 115,323 Direct | -25.61% | Disposed | 127.2% (price as of 2026-08-19) |
| Dec. 2, 2025 | VIAV | S | 25,100 | $17.84 | $447,784 | 155,032 Direct | -13.93% | Disposed | 121.9% (price as of 2026-08-19) |
| June 4, 2025 | VIAV | S | 82,095 | $9.28 | $761,842 | 0 Direct | -100.00% | Disposed | 326.6% (price as of 2026-08-19) |
| Sept. 3, 2021 | BIO | S | 270 | $820.06 | $221,416 | 9 Direct | -96.77% | Disposed | -55.7% (price as of 2026-08-19) |
| Sept. 2, 2021 | BIO | S | 100 | $828.01 | $82,801 | 7 Direct | -93.46% | Disposed | -56.1% (price as of 2026-08-19) |
| Sept. 2, 2021 | BIO | S | 440 | $828.00 | $364,320 | 107 Direct | -80.44% | Disposed | -56.1% (price as of 2026-08-19) |
| Aug. 4, 2021 | BIO | S | 489 | $753.32 | $368,373 | 7 Direct | -98.59% | Disposed | -51.8% (price as of 2026-08-19) |
| Aug. 4, 2021 | BIO | S | 954 | $751.98 | $717,389 | 496 Direct | -65.79% | Disposed | -51.7% (price as of 2026-08-19) |
| Aug. 4, 2021 | BIO | S | 857 | $750.85 | $643,478 | 1,450 Direct | -37.15% | Disposed | -51.6% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 28, 2025 | VIAV | Restricted Stock Unit | Common Stock (37,879) | $0.00 | — | 37,879 | Disposed |
| Nov. 28, 2025 | VIAV | Restricted Stock Unit | Common Stock (65,944) | $0.00 | — | 65,944 | Disposed |
| Nov. 28, 2025 | VIAV | Market Stock Units | Common Stock (35,984) | $0.00 | — | 35,984 | Disposed |
| Nov. 28, 2025 | VIAV | Market Stock Units | Common Stock (62,645) | $0.00 | — | 62,645 | Disposed |
| Sept. 23, 2025 | VIAV | Market Stock Units | Common Stock (62,645) | $0.00 | — | 62,645 | Acquired |
| Sept. 23, 2025 | VIAV | Market Stock Units | Common Stock (35,984) | $0.00 | — | 35,984 | Acquired |
| Sept. 23, 2025 | VIAV | Market Stock Units | Common Stock (70,545) | $0.00 | — | 70,545 | Disposed |
| Aug. 28, 2025 | VIAV | Market Stock Units | Common Stock (142,258) | $0.00 | — | 142,258 | Acquired |
| Aug. 28, 2025 | VIAV | Restricted Stock Unit | Common Stock (142,258) | $0.00 | — | 142,258 | Acquired |
| Aug. 28, 2025 | VIAV | Restricted Stock Unit | Common Stock (55,115) | $0.00 | — | 55,115 | Disposed |
| Nov. 28, 2024 | VIAV | Restricted Stock Unit | Common Stock (37,879) | $0.00 | — | 37,879 | Disposed |
| Nov. 28, 2024 | VIAV | Restricted Stock Unit | Common Stock (65,944) | $0.00 | — | 65,944 | Disposed |
| Nov. 28, 2024 | VIAV | Market Stock Units | Common Stock (22,851) | $0.00 | — | 22,851 | Disposed |
| Nov. 28, 2024 | VIAV | Market Stock Units | Common Stock (39,783) | $0.00 | — | 39,783 | Disposed |
| Sept. 24, 2024 | VIAV | Market Stock Units | Common Stock (22,851) | $0.00 | — | 22,851 | Acquired |
| Sept. 24, 2024 | VIAV | Market Stock Units | Common Stock (39,783) | $0.00 | — | 39,783 | Acquired |
| Aug. 28, 2024 | VIAV | Restricted Stock Unit | Common Stock (165,343) | $0.00 | — | 165,343 | Acquired |
| Aug. 28, 2024 | VIAV | Market Stock Units | Common Stock (165,343) | $0.00 | — | 165,343 | Acquired |
| Nov. 28, 2023 | VIAV | Restricted Stock Unit | Common Stock (263,774) | $0.00 | — | 263,774 | Acquired |
| Nov. 28, 2023 | VIAV | Restricted Stock Unit | Common Stock (113,636) | $0.00 | — | 113,636 | Acquired |
| Nov. 28, 2023 | VIAV | Market Stock Units | Common Stock (263,774) | $0.00 | — | 263,774 | Acquired |
| Nov. 28, 2023 | VIAV | Market Stock Units | Common Stock (113,636) | $0.00 | — | 113,636 | Acquired |
| Sept. 2, 2023 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (542) | — | — | 542 | Disposed |
| Sept. 1, 2023 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (456) | — | — | 456 | Disposed |
| Sept. 1, 2023 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (694) | — | — | 694 | Disposed |
| Sept. 1, 2023 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (4,007) | — | — | 4,007 | Acquired |
| April 8, 2023 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (700) | — | — | 700 | Disposed |
| Sept. 2, 2022 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (541) | — | — | 541 | Disposed |
| Sept. 1, 2022 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (455) | — | — | 455 | Disposed |
| Sept. 1, 2022 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (2,776) | — | — | 2,776 | Acquired |
| April 8, 2022 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (700) | — | — | 700 | Disposed |
| Sept. 2, 2021 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (541) | — | — | 541 | Disposed |
| Sept. 2, 2021 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (540) | $524.30 | Sept. 2, 2030 | 540 | Disposed |
| Sept. 1, 2021 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (1,823) | $814.95 | Sept. 1, 2031 | 1,823 | Acquired |
| Sept. 1, 2021 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (1,823) | — | — | 1,823 | Acquired |
| Aug. 4, 2021 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (1,400) | $309.84 | April 8, 2029 | 1,400 | Disposed |
| April 8, 2021 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (700) | — | — | 700 | Disposed |
| April 8, 2020 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (700) | — | — | 700 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
BIO
CFO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $565,093 | — | — | — | — | — | $20,112 | $2,655,971 |
| 2019 | $365,385 | — | $1,084,440 | $299,263 | $256,259 | — | $1,412 | $2,006,759 |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $570,003 | — | $3,105,142 | — | $292,127 | — | $5,000 | $3,972,272 |
| 2024 | $352,964 | $500,000 | $6,620,784 | — | — | — | $5,000 | $7,478,748 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.